Tiverton Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$120K Hold
1,550
﹤0.01% 624
2019
Q2
$160K Hold
1,550
0.01% 577
2019
Q1
$113K Buy
+1,550
New +$113K ﹤0.01% 569